Skip to main content

Table 1 Baseline characteristics

From: Silent diabetic cardiomyopathy in everyday practice: a clinical and echocardiographic study

  Control
(N = 80)
Group I (DM)
(N = 70)
Group II (DM+HTA)
(N = 70)
Group III (DM+CAD)
(N = 70)
p
Age (years) 54.8 ± 4.9 54.8 ± 7.7 54.6 ± 5.8 55.3 ± 5.4 0.924
Female, n (%) 36 (45.0) 32 (45.7) 32 (45.7) 32 (45.7) 1.000
BMI (kg/m2) 25.7 ± 3.7* 27.5 ± 3.4 28.4 ± 4.6 28.2 ± 3.6 <0.001
Hyperlipidemia n (%) 15 (18.8) * 35 (50.0) 34 (48.6) 36 (51.4) <0.001
Obesity (BMI > 30.0) 13 (16.2)* 23 (32.9) 22 (31.4) 23 (32.9) 0.057
DM duration (years) - 7.7 ± 4.9§ 9.9 ± 5.3 9.2 ± 5.2 0.014
Blood glucose level (mmol/l) - 7.5 ± 1.5 7.7 ± 1.5 8.0 ± 1.5 0.110
HbA1c (%) - 6.95 ± 0.85Δ 7.08 ± 0.98 7.34 ± 1.07 0.040
Cholesterol (mmol/l) 5.01 ± 0.89* 5.78 ± 1.22 5.67 ± 1.13 5.78 ± 1.02 <0.001
Triglycerides (mmol/l) 1.77 ± 0.57* 2.46 ± 1.36 2.42 ± 1.14 2.49 ± 0.99 <0.001
Retinopathy n (%) - 15 (21.4) 26 (37.1) 20 (28.6) 0.122
Microalbuminura n (%) - 13 (18.6)§ 27 (38.6) 19 (27.1) 0.031
  1. *p < 0.05 control vs DM; #p < 0.05 control vs DM+HTA; ¤p < 0.05 control vs DM+CAD
  2. §p < 0.05 DM vs DM+HTA
  3. Δp < 0.05 DM vs DM+CAD